• Pharmaceuticals & Biopharmaceuticals
  Development and manufacturing of chemical, biological and biosimilar medicines; strong competencies in organic synthesis, drug discovery and active pharmaceutical ingredients.

• Medical Technologies & Devices
  Production of diagnostic equipment, wearable technologies, implants, laser systems, smart materials and high-precision optical components.

• Precision Medicine & Genomics
  Research in personalised therapies, genomic sequencing, biomarker discovery and big-data–driven health solutions.

• Biotechnology & Industrial Biotech
  Innovations in fermentation technologies, enzymes, cell-based solutions, bioprocessing and sustainable bio-based materials.

• Translational Medicine & Clinical Research
  Strong academic–industry cooperation supporting preclinical and clinical studies, laboratory testing, and technology transfer pathways.

• Digital Health & HealthTech
  Development of e-health tools, medical software, telemedicine platforms, decision-support systems and AI-powered healthcare applications.

• Latvia is a regional leader in precision medicine, genomic research and biomedical big-data infrastructure.

• 76% of Latvia-made chemical and pharmaceutical products are exported.

• The sector includes 500+ companies across pharmaceuticals, biotechnology, chemicals and medical devices.

• Latvia offers one of the most competitive price-to-quality ratios for research clean-room facilities in Northern Europe.

• Strong institutional base includes the Latvian Biomedical Research and Study Centre (BMC) and the Latvian Institute of Organic Synthesis, both internationally recognised.

• Latvian-made biomedical products reach global markets such as Japan, the USA, Canada and the EU.

• Growing investment in digital health, precision diagnostics, biotechnology and next-generation medical technologies.

• Established EU-aligned regulatory environment ensures high quality standards for research, clinical trials and manufacturing.

• The chemical and pharmaceutical manufacturing industry is one of Latvia’s largest high-value export sectors, with more than three-quarters (76%) of its output sold abroad.

• The sector comprises 500+ companies, ranging from pharmaceuticals and biotechnology to medical devices, diagnostics, and chemical production.

• Latvia’s pharmaceutical and biopharmaceutical manufacturers contribute a significant share to national manufacturing turnover, consistently ranking among the top industrial sub-sectors.

• The sector demonstrates steady year-on-year export growth, driven by increased demand for chemical products, active ingredients, and medical technologies across Europe and global markets.

• Latvia hosts several internationally recognised research institutions — including the Latvian Biomedical Research and Study Centre and the Latvian Institute of Organic Synthesis — which together produce a high volume of scientific publications, patents, and commercialised technologies.

• Investment in biotechnology, medical technology and laboratory infrastructure has grown substantially in recent years, supported by EU programmes and national innovation funding.

• The sector employs a highly skilled workforce, including chemists, molecular biologists, pharmacists, engineers and data scientists, many trained through strong national life-science programmes.

• Latvia’s alignment with EU regulatory frameworks ensures high manufacturing, research and clinical-trial quality, supporting competitive market access to Europe and beyond.

• The biomedicine sector employs a highly skilled workforce, including chemists, pharmacists, molecular biologists, biotechnologists, engineers and data scientists.

• Latvia’s life-science talent pipeline is supported by strong academic programmes at the University of Latvia, Rīga Stradiņš University, and the Latvia University of Life Sciences and Technologies, offering degrees in pharmacy, biology, chemistry, biotechnology, medicine and biomedical engineering.

• Leading research institutions — including the Latvian Biomedical Research and Study Centre and the Latvian Institute of Organic Synthesis — provide advanced training, doctoral programmes and hands-on research experience.

• Continuous collaboration between universities, research centres and industry ensures skills development in emerging fields such as precision medicine, genomics, biostatistics, bioprocessing, and digital health technologies.

• Research facilities offer access to state-of-the-art laboratories, clean-room environments, and biomedical big-data infrastructure, enabling workforce training aligned with international standards.

• The sector attracts both local and international professionals, reflecting Latvia’s growing role as a regional hub for life-science innovation.

• Grindeks
  One of Latvia’s largest pharmaceutical manufacturers, specialising in cardiovascular, oncological and CNS medications, as well as active pharmaceutical ingredients (APIs). Products are exported to 100+ countries worldwide.

• Olainfarm
  A major pharmaceutical company producing finished dosage forms, chemical substances and intermediates. Strong presence in European and global markets with a broad portfolio of medicines and high-quality manufacturing standards.

• Latvian Institute of Organic Synthesis (LIOS)
  Latvia’s leading drug-discovery and organic synthesis competence centre, internationally recognised for developing new biologically active compounds, APIs and technologies used by global pharmaceutical companies.

• Latvian Biomedical Research and Study Centre (BMC)
  The country’s flagship institution for genomics, molecular biology and biotechnology. A key driver of precision medicine, biobank development and biomedical big-data initiatives.

• Cellbox Labs
  A fast-growing biotech company developing advanced in vitro human cell models and regenerative medicine technologies for drug development and toxicity testing.

• Longenesis
  A digital-health and consent-management platform enabling secure biomedical data use, patient engagement and clinical research collaborations across international markets.

• CastPrint
  A leading medical 3D-printing company producing custom orthopaedic solutions and personalised immobilisation devices for hospitals and clinics worldwide.

• Meditec
  One of Latvia’s key health-tech companies, providing national-scale e-health, hospital information systems and digital medical infrastructure solutions.

 ​​​Latvia’s healthcare sector offers strong growth potential, supported by a combination of highly qualified medical professionals, competitive operational costs, and modern clinical and research facilities. The country is also home to a growing ecosystem of innovative health-tech start-ups — including Anatomy Next, CastPrint, and CheeksUp — which have gained international recognition for their advanced digital and medical solutions. To get further information on Healthcare sector in Latvia click here.

 Latvia’s life science sector is one of the country’s strongest innovation engines — driving growth, competitiveness, and the development of sustainable, high value–added products and services. With deep historical roots in Latvia’s scientific tradition, the sector today combines robust R&D capacity, an established manufacturing base, and a strategic geographical and cultural position that connects Eastern and Western markets. To get further information on Life science sector in Latvia click here.